Jeil Pharmaceutical Co.,Ltd

KRX:271980.KS

14950 (KRW) • At close October 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q3
Operating Activities:
Net Income -26,512.773-2,877.846-2,237.145-4,625.228-1,754.42514,523.418-4,199.257-4,389.171-1,973.086-4,447.5-13,722.147-794.7711,326.858-1,795.558329.584424.4042,391.5593,819.255-14,069.0571,139.1672,000.551344.746825.209533.16187.041343.623360.458491.563
Depreciation & Amortization 2,903.5942,673.6312,590.4542,380.9122,454.3882,341.3462,310.5882,241.4072,201.4212,132.8192,313.8712,303.782,275.6312,239.322,224.862,245.6872,287.0392,235.2762,010.5881,885.2571,867.8481,842.2751,904.4181,600.4341,602.7821,517.73300
Deferred Income Tax 00-80.922-48.827-6,535.2640000010,109.1071,799.440000000000000000
Stock Based Compensation 0213.5526.695233.465224.55893.309215.81395.647108.33852.682115.53624.0570000000000000000
Change In Working Capital -5,198.873-369.59311,609.065-15,962.88212,824-29,159.02-5,861.5132,438.625-15,345.2273,612.89180.0766,312.5436,313.291,811.1632,920.963-12,317.653-20,628.527-9,762.49312,605.919-9,040.8167,967.43310,032.956-825.758-7,476.6996,316.0219,095.57200
Accounts Receivables -2,021.516,057.5312,477.38-16,054.3917,957.257-14,283.5835,614.98710,934.579-16,979.373-5,614.29613,848.5986,367.046-2,768.988-6,796.77300000000000000
Change In Inventory -3,497.49-6,195.54416,703.892-10,383.834337.996-17,232.7333,837.591-2,481.869-3,625.9335,832.221-113.5774,732.043634.1131,081.5294,795.487-7,873.586-9,688.551-13,850.974-4,134.512,719.1498,913.057-3,261.158-2,845.951-6,331.609136.3413,650.71800
Change In Accounts Payables -3,167.1584,565.887-14,054.59112,485.935-7,583.5781,532.464-6,440.011-6,031.2095,919.5594,887.479-3,788.002416.485,849.1497,147.04400000000000000
Other Working Capital 320.127-4,797.4676,482.384-2,010.5932,112.325824.832-8,874.0817.124-659.48-2,219.331293.6531,580.55,679.177729.634-1,874.524-4,444.06704,088.48116,740.429-11,759.965-945.62413,294.1142,020.193-1,145.096,179.685,444.85400
Other Non Cash Items 27,900.4662,039.2452,065.341,417.9241,235.161,403-238.4951,999.6612,430.1861,467.182465.203307.585-3,251.129766.391,181.9871,368.429248.915282.9884,447.8462,446.996677.812,798.1053,576.337955.9521,934.795-637.2686,390.001-9,654.205
Operating Cash Flow -907.586546.04913,973.487-16,604.6368,448.417-10,797.947-7,772.8642,386.169-12,578.3682,818.073-538.3549,952.6346,664.653,021.3156,657.394-8,279.133-13,999.373-3,424.9744,995.296-3,569.39612,513.64215,018.0825,480.206-4,387.15310,040.63910,319.666,750.459-9,162.642
Investing Activities:
Investments In Property Plant And Equipment -637.804-1,897.002-2,521.12-1,826.88-1,957.719-3,270.142-2,605.796-12,139.37-1,177.206-1,035.818-2,677.212-981.296-1,096.088-638.042-407.513-979.164-691.267-789.007-414.495-431.205-181.657-368.426-1,324.916-707.846-4,954.229-3,299.523-1,407.582-2,208.06
Acquisitions Net 6.35014.636067626,002.05300.58027,497.61,500.001-3,000000599.995000-114.449000000
Purchases Of Investments -3,128.139-174.613,778.91-25.8-9,308.42-0-26,002.0530-0.5071.9274.907-143.114-3.713-3,335.543-200.0028.986-13.6871,828.2770-1,835.039-178.236000000
Sales Maturities Of Investments 2,785.36802,888.6530142.458-61,509.203-2,007.6223.382,392.643654.5260114.016-8.714000-44.067000350000000
Other Investing Activites -1,634.49134092.81.0085.240.76-13.51,991.4640.5158-1,345.474085.9849.664-26.79518.222-29.438284.0670057142.176-367.2767.415137.905100-2,982.023-667.318
Investing Cash Flow -2,272.294-1,731.6114,253.879-1,851.671-11,051.44-3,269.382-1,110.094-12,155.528-1,173.3261,514.825-3,950.765-906.388460.799-3,640.805-3,769.85-1,160.943-683.48437.3011,413.782-431.205-1,959.696-168.935-1,692.192-700.431-4,816.324-3,199.523-4,389.604-2,875.378
Financing Activities:
Debt Repayment -546.683-89.794-11,269.304-9,771.409-14,576.234-2,500-1,734.981-2,093.75-1,427.406-1,635.094-3,876.284-1,031.172-6,161.398-3,371.718-3,062.50-1,531.25-1,531.25-9,531.25-3,062.5-2,500-1,879.583-7,827.505-7,207.087-17,257.521-6,057.1070-439.885
Common Stock Issued 0000000000000000000000000000
Common Stock Repurchased 000000000-396.983-731.46-78.563000000-1,827.277000000000
Dividends Paid -728.378000-728.378000-947.735000-1,022.339000000000-000000
Other Financing Activities 3,490.393-0-635.8118,983.6328,682.99210,580.03225,409.13414,472.9071,585.025-560.984-611.2041,383.287-1,527.0526,995.7531,164.4647,044.7720-445.3792,584.574-164.636-132.394-75.94903,541.98110,058.8050-2,129.74818,516.469
Financing Cash Flow 2,215.332-471.292-11,905.1149,212.22113,378.388,080.03223,674.15312,379.157157.618-2,593.061-5,218.947352.115-7,688.44823,624.035-1,898.0367,044.77211,962.978-1,976.629-8,773.953-3,227.136-2,632.394-1,955.532-7,827.504-3,665.106-7,198.716-6,057.107-2,129.74718,076.584
Other Information:
Effect Of Forex Changes On Cash 235.31396.453-396.664-3.16485.112-6.859-219.12255.172-76.922-22.931-49.4194.32-21.4914.554-149.4436.507-136.308147.427-337.50963.35368.9832.548-9.383-363.039252.741110.33-187.463-78.786
Net Change In Cash -729.238-1,260.4025,925.588-9,247.2510,860.469-5,994.15514,572.0752,864.97-13,670.9981,716.907-9,757.4859,402.681-584.4923,009.099840.065-2,388.798-2,856.188-5,216.876-2,702.385-7,164.3847,990.53512,896.164-4,048.873-9,115.729-1,721.6591,173.35943.6455,959.777
Cash At End Of Period 31,001.24631,730.48432,990.88627,065.29836,312.54825,452.07931,446.23416,874.15814,009.18827,680.18625,963.27935,720.76426,318.08326,902.5733,893.4743,053.4095,442.2078,298.39513,515.27116,217.65523,382.03915,391.5042,495.346,544.21315,659.94217,381.60116,208.24216,164.597